M Lobisch
Impact in
- Biochemistry top 0.5%
- Biochemical Acid Research Studies
- Neurology top 5%
- Alcoholism and Thiamine Deficiency
- Botulinum Toxin and Related Neurological Disorders
- Neurological Disorders and Treatments
- Parkinson's Disease Mechanisms and Treatments
Papers in
-
- Biochemical Acid Research Studies 5
-
- Botulinum Toxin and Related Neurological Disorders 2
- Neurological disorders and treatments 1
- Co-authors
- Dan Ziegler (3 shared papers)M Hanefeld (2 shared papers)F. A. Gries (1 shared paper)Hans Tritschler (3 shared papers)H Hasche (1 shared paper)R. Maleßa (1 shared paper)Gorazd Kerum (1 shared paper)M. Reljanović (2 shared papers)
- Journals
- Diabetes Care (1 paper)Diabetes Technology & Therapeutics (1 paper)Diabetic Medicine (1 paper)Diabetologia (1 paper)Free Radical Research (1 paper)
- Partner nations
- GermanyCroatiaUnited States
In The Last Decade
M Lobisch
14 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 72
- Biochemistry 511
- Neurology 351
- Clinical Biochemistry 113
- Physiology 383
- Neurology 112
Countries citing papers authored by M Lobisch
This map shows the geographic impact of M Lobisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Lobisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Lobisch more than expected).
Fields of papers citing papers by M Lobisch
This network shows the impact of papers produced by M Lobisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Lobisch. The network helps show where M Lobisch may publish in the future.
Co-authors
The 25 scholars most cited alongside M Lobisch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 404 | |
| 2 | 1999 | 292 | |
| 3 | 1999 | 194 | |
| 4 | 1999 | 115 | |
| 5 | 2003 | 24 | |
| 6 | [Treatment of tumor pain with flupirtine. Results of a double-blind study versus tramadol]. | 1994 | 22 |
| 7 | [Effectiveness of flupirtine in chronic tension headache. Results of a double-blind study versus placebo]. | 1995 | 13 |
| 8 | 2000 | 12 | |
| 9 | [Long-term tolerance of flupirtine. Open multicenter study over one year]. | 1993 | 11 |
| 10 | 2000 | 7 | |
| 11 | [Long-term experiences with continuous peridural opiate analgesia with an implanted pump]. | 1984 | 6 |
| 12 | [Clinical pilot study of the myogenic effects of flupirtine in comparison to tetrazepam and placebo]. | 1996 | 4 |
| 13 | 2004 | 2 | |
| 14 | 2007 | 1 |
About M Lobisch
M Lobisch is a scholar working on Biochemistry, Neurology, Physiology, Psychiatry and Mental health and Endocrinology, Diabetes and Metabolism, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Biochemical Acid Research Studies (5 papers), Migraine and Headache Studies (3 papers), Pain Mechanisms and Treatments (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Alzheimer's disease research and treatments (1 paper), Neurological disorders and treatments (1 paper), Acupuncture Treatment Research Studies (1 paper) and Advanced Glycation End Products research (1 paper). The work is most often cited by research in Biochemistry (511 citations), Neurology (351 citations), Clinical Biochemistry (113 citations), Physiology (383 citations) and Neurology (112 citations). M Lobisch has collaborated with scholars based in Germany, Croatia and United States. Frequent co-authors include Dan Ziegler, M Hanefeld, F. A. Gries, Hans Tritschler, H Hasche, R. Maleßa, Gorazd Kerum, M. Reljanović, H. Mehnert and K. Rett. Their work appears in journals such as Diabetes Care, Diabetes Technology & Therapeutics, Diabetic Medicine, Diabetologia and Free Radical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.